DATA MINING INTERNATIONAL SA

Their core work

DATA MINING INTERNATIONAL SA is a Geneva-based data science SME that applies statistical and data mining methods to health research problems, particularly large-scale epidemiological datasets. Their work in the REMEDIA project involves analyzing how environmental exposures (the exposome) affect the progression of lung diseases through retrospective epidemiological studies — meaning they work with existing patient cohorts and environmental records rather than running new clinical trials. In the earlier VALUeHEALTH project, they contributed analytical capacity to assess the value and viability of eHealth service models across Europe. In short, they are a health data analytics firm that embeds into research consortia to handle the computational and statistical heavy lifting.

What they specialise in

How they've shifted over time

In 2015–2017, DMI worked on eHealth systems and digital health service economics — a more policy- and market-oriented application of their data skills. By 2020, their focus shifted sharply toward environmental epidemiology, specifically the relationship between cumulative environmental exposures (exposomes) and chronic respiratory conditions such as lung diseases. This represents a move from digital health infrastructure toward clinical and environmental data science, suggesting they followed demand toward the growing exposome research field, which gained significant EU funding momentum in this period.

DMI appears to be positioning itself as a specialist data mining partner in large environmental health and chronic disease consortia, where complex multi-source data integration is a bottleneck few SMEs can fill.

How they like to work

DMI has never led an H2020 project — they always join as a participant, acting as a specialist analytical contributor within larger consortia. Their two projects involved a combined 25 unique partners across 10 countries, indicating they operate comfortably inside large, multi-national research teams rather than small bilateral collaborations. This pattern suggests they are brought in for a defined technical role — data mining, statistical analysis — rather than for project management or scientific leadership.

DMI has worked with 25 unique consortium partners spanning 10 countries across two projects, suggesting exposure to a broad European research network despite their small project count. Being Geneva-based gives them proximity to WHO, international health organizations, and a dense cluster of global health institutions, which likely informs the international character of their partnerships.

What sets them apart

DMI fills a specific and underserved niche: a private SME with data mining expertise that can work inside academic health research consortia, handling the analytical tasks that university partners often lack the capacity or commercial flexibility to execute efficiently. Their Geneva location places them in one of Europe's most connected hubs for global health research, giving them access to networks most national SMEs cannot easily reach. For consortium builders, they represent a technically credible, commercially agile partner for projects requiring heavy epidemiological data processing.

Highlights from their portfolio

• REMEDIA
  The largest and most recent project (EUR 776,913 EC funding, running to 2025), focused on the emerging exposome field — one of the most data-intensive areas in current health research, requiring exactly the kind of multi-source data mining DMI specializes in.
• VALUeHEALTH
  Shows DMI's earlier versatility — applying data analytics not just to clinical datasets but to the business and policy economics of eHealth services across Europe.